AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9822485
Drug: Intramuscular dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular dexamethasone (6 mg every 12 hours for 4 doses, repeated weekly until 34 weeks' gestation)
Trial: 9822485
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (8 mg every 12 hours for 4 doses, repeated weekly until 34 weeks' gestation)
Trial: 7858362
Drug: i.v.‐PCA ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v.‐PCA ketorolac 5 mg/ml
Trial: 7858362
Drug: i.v.‐PCA morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v.‐PCA morphine 1 mg/ml
Trial: 30792143
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g PS
Trial: 30792143
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g OBG
Trial: 30792143
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g PS and 3 g OBG
Trial: 28640772
Drug: Carbohydrate mouth
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate mouth rinse (25 ml of an 18% CHO solution)
Trial: 17267793
Drug: Extended-release venlafaxine
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release venlafaxine
Trial: 7648784
Drug: Insulin modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin modified FSIVGTT (insulin infusion at 4 mUkg‐1.min‐1 from time 20 to 25 min)
Trial: 7648784
Drug: Standard FSIVGTT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard FSIVGTT (glucose infusion of 0.3 g/kg from time 0 to 2 min)
Trial: 2953752
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate administered daily for 4 weeks followed by concomitant hMG administration
Trial: 31251544
Drug: Low-density MFU-V
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-density MFU-V treatments
Trial: 31251544
Drug: High-density MFU-V
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-density MFU-V treatments
Trial: 31251544
Drug: High-density MFU-V
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-density MFU-V treatment
Trial: 27068760
Drug: Anti-malarial treatment
RxNorm normalized name: malarial plasmodium group immunoserum rabbit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-malarial treatment (specific dosage and duration not provided)
Trial: 24558011
Drug: Hot drink
RxNorm normalized name: Nature's Way Cold Relief Hot Drink Lemon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hot drink (paracetamol)
Trial: 24558011
Drug: Tablet (paracetamol)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet (paracetamol)
Trial: 22721545
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) - 1 g loading dose followed by 1 g maintenance dose over 8 hours
Trial: 17227744
Drug: Homeopathic combination
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic combination medication
Trial: 15943961
Drug: Oxytrex bid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytrex bid (twice a day)
Trial: 17157780
Drug: Oxycodone qid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone qid
Trial: 12213107
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg day(-1))
Trial: 7704460
Drug: Slow‐acting anti‐rheumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow‐acting anti‐rheumatic drugs (SAARD)
Trial: 2696292
Drug: 3% Felbinac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% Felbinac gel (1 or 2 g)
Trial: 2696292
Drug: Oral Fenbufen
RxNorm normalized name: fenbufen
DrugBank: Fenbufen (DB08981)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Fenbufen (300 mg thrice daily)
Trial: 2696292
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration (Felbinac gel)
Trial: 2696292
Drug: Skin tissue
RxNorm normalized name: skin tissue adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin tissue concentrations after topical administration
Trial: 773080
Drug: Madopar (L-Dopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Madopar (L-Dopa + benserazid)
Trial: 28120127
Drug: ONO-8539 (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-8539 (450 mg)
Trial: 25644589
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment during follow-up
Trial: 24702710
Drug: AS03-adjuvanted inactivated
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03-adjuvanted inactivated trivalent split-virion influenza vaccine (AS03-TIV)
Trial: 24702710
Drug: Non-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted vaccine (TIV)
Trial: 22348696
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus 1.2-mg SMV
Trial: 18069280
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HDT) followed by autologous stem cell transplantation (SCT)
Trial: 18069280
Drug: New drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drugs including thalidomide, lenalidomide, or bortezomib in combination with SCT
Trial: 9308335
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for epilepsy
Trial: 6870066
Drug: Vasodilator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasodilator therapy (hydralazine or nifedipine) for Group I; nitroprusside followed by minoxidil or hydralazine for Group II.
Trial: 28389025
Drug: 4-implant group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-implant group
Trial: 21029429
Drug: Ibuprofen, 600
RxNorm normalized name: Ibuprofen, 600 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 600 mg thrice daily
Trial: 15813357
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment after the first seizure
Trial: 15813357
Drug: Rectal diazepam
RxNorm normalized name: diazepam Rectal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal diazepam at seizure onset
Trial: 1916649
Drug: met‐hGH (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: met‐hGH (0.08 mg/kg desirable body weight)
Trial: 25228126
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of prednisone daily for 2 years
Trial: 23230115
Drug: High nitrogen
RxNorm normalized name: Isosource High Nitrogen Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High nitrogen (HN; CON plus urea supplement)
Trial: 19913145
Drug: ETG-releasing implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETG-releasing implant
Trial: 16762627
Drug: Entecavir 1
RxNorm normalized name: entecavir 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir 1 mg daily
Trial: 7956657
Drug: ThinPrep preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ThinPrep preparation
Trial: 3604619
Drug: 5,000 IU
RxNorm normalized name: bleopmycin 15,000 IU Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 IU heparin and 0.5 mg dihydroergotamine injected subcutaneously twice daily
Trial: 27545858
Drug: NTP‐CE (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTP‐CE (new topical panthenol‐containing emollient)
Trial: 19353407
Drug: Active antihypertensive
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antihypertensive treatment (indapamide 1.5 mg sustained release +/‐2‐4 mg perindopril)
Trial: 12717213
Drug: Daclizumab 1
RxNorm normalized name: daclizumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 1 mg/kg per dose every 14 days for five doses (group I, n=107)
Trial: 12717213
Drug: Daclizumab 2
RxNorm normalized name: daclizumab 25 MG per 5 ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 2 mg/kg per dose every 14 days for two doses (group II, n=112)
Trial: 12717213
Drug: No antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibody induction (group III, n=78)
Trial: 12717213
Drug: Daclizumab 1
RxNorm normalized name: daclizumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 1 mg/kg per dose every 14 days for five doses (group I)
Trial: 12717213
Drug: Daclizumab 2
RxNorm normalized name: daclizumab 25 MG per 5 ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 2 mg/kg per dose every 14 days for two doses (group II)
Trial: 12717213
Drug: No antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibody induction (group III)
Trial: 24286472
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of adalimumab (ADA)
Trial: 19186727
Drug: Acupoint stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint stimulating therapy
Trial: 15086180
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy during colonoscopy, n=15
Trial: 9731580
Drug: HCV RNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV RNA level > 100 x 10(5) Eq/mL at 1 month after transplantation
Trial: 2807006
Drug: Radiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy plus twice-weekly cis-platinum (group III)
Trial: 2807006
Drug: Radiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy plus weekly cis-platinum (group II)
Trial: 23073143
Drug: 100-mg sarpogrelate
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-mg sarpogrelate IR 3 times at a 6-h interval
Trial: 23073143
Drug: 300-mg sarpogrelate
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300-mg sarpogrelate CR once
Trial: 20624624
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg for 7 days before surgery
Trial: 20624624
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg for 7 days before surgery
Trial: 17147088
Drug: Senna 12
RxNorm normalized name: senna 12 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna 12 mg and Magnesium Sulphate 15 mg the day before colonoscopy
Trial: 17147088
Drug: Polyethylene Glycol-based
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene Glycol-based solution of two litres plus 4 tablets of Bisacodyl the day before the exam
Trial: 10720544
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF; 0.3 mg/mL 3 times a week) for 12 weeks
Trial: 1337322
Drug: Molsidomine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (16 mg)
Trial: 24773615
Drug: Tribulus terrestris
RxNorm normalized name: TRIBULUS TERRESTRIS
DrugBank: Tribulus terrestris (DB14358)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribulus terrestris extract (7.5 mg/day)
Trial: 23021433
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral glutamine (0.5 g kg(‐1) d(‐1)) for 4 months
Trial: 23021433
Drug: Acute oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute oral glutamine (0.5 g kg(‐1) d(‐1)) for 5 hours
Trial: 16054408
Drug: Socio-economic factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Socio-economic factors (e.g. financial strain)
Trial: 12848286
Drug: High-DHA eggs
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-DHA eggs (135 mg DHA/egg)
Trial: 12848286
Drug: Ordinary eggs
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary eggs (18 mg DHA/egg)
Trial: 9004188
Drug: Multi-segment absorption
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-segment absorption model for diclofenac sodium
Trial: 9004188
Drug: Conventional pharmacokinetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pharmacokinetic method (first-order absorption)
Trial: 9004188
Drug: Multi-segment absorption
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-segment absorption models
Trial: 1480873
Drug: Manual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual treatment of pelvic joint dysfunction
Trial: 1480873
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (massage)
Trial: 3758947
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (0.6 microgram) + Hepatitis B immune globulin (500 IU)
Trial: 3758947
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine only (0.6 microgram)
Trial: 24849077
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (self-measurement of pressure pain sensitivity followed by acupressure)
Trial: 22273342
Drug: Nurse-led cognitive
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led cognitive behavioral group therapy once a week for 12 weeks
Trial: 22273342
Drug: Nurse-led cognitive
RxNorm normalized name: PAD,NURSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led cognitive behavioral group therapy
Trial: 8694673
Drug: Valaciclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 500 mg
Trial: 8694673
Drug: Valaciclovir 1000
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 1000 mg
Trial: 12534609
Drug: Valaciclovir 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 2000 mg
Trial: 7828385
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg lifibrol for 4 weeks
Trial: 7828385
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lifibrol for 4 weeks
Trial: 7828385
Drug: 450 mg
RxNorm normalized name: aspirin 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg lifibrol for 4 weeks
Trial: 7828385
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lifibrol for 4 weeks
Trial: 7828385
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg lifibrol for 4 weeks
Trial: 7828385
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg lifibrol for 12 weeks
Trial: 7828385
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg lifibrol for 12 weeks
Trial: 7828385
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lifibrol for 12 weeks
Trial: 2193858
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid administration (50 mg Ultracortene‐H) with 2 mg morphine hydrochloride
Trial: 2193858
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine hydrochloride without Ultracortene‐H
Trial: 23662047
Drug: Olmesartan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan plus Azelnidipine (16 mg/day)
Trial: 23662047
Drug: Olmesartan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan plus Amlodipine (5 mg/day)
Trial: 21566261
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg DHEA once daily
Trial: 10980214
Drug: Fosinopril 20
RxNorm normalized name: fosinopril 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril 20 mg/day
Trial: 10980214
Drug: Fosinopril 20
RxNorm normalized name: fosinopril 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril 20 mg/day and Pravastatin 40 mg/day
Trial: 3490077
Drug: Periurethral injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periurethral injections of 10 ml 0.25% Bupivacaine, administered three times in 2-week intervals.
Trial: 28339166
Drug: Avatrombopag; single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avatrombopag; single doses under fasted and fed conditions.
Trial: 28339166
Drug: Avatrombopag; single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avatrombopag; single dose.
Trial: 28339166
Drug: Avatrombopag; general
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avatrombopag; general administration.
Trial: 22474954
Drug: Topical ointment
RxNorm normalized name: Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ointment prepared from Morinda citrifolia stem extract
Trial: 20837589
Drug: Stimulant monotherapy
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant monotherapy optimization with methylphenidate preparation (once-daily, triphasic release) and behavioral therapy
Trial: 18394875
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate combination (SFC) 50microg/250microg + 1 placebo tablet
Trial: 17050557
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate combination (SFC)
Trial: 7706786
Drug: Synthetic verotoxin
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic verotoxin (VT, shiga‐like toxin) Pk‐trisaccharide receptor sequences attached to Chromosorb (Synsorb‐Pk)
Trial: 1980979
Drug: Synthetic detergent
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic detergent preparation of pH 5.5
Trial: 1980979
Drug: Synthetic detergent
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic detergent preparation of pH 7.0
Trial: 7234652
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment or minor analgesic therapy
Trial: 7234652
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and Indomethacin
Trial: 30621789
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (prompt infertility treatment)
Trial: 27254026
Drug: Chemotherapy (Cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Cisplatin and 5-fluorouracil)
Trial: 27254026
Drug: Chemoradiotherapy (Cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiotherapy (Cisplatin and 5-fluorouracil with concurrent radiotherapy 40 Gy)
Trial: 17627724
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment protocol (ITP) with sildenafil and cognitive-behavior sex therapy (CBST) for the first 4 weeks, followed by continued ITP for the last 4 weeks
Trial: 17627724
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment protocol (ITP) with sildenafil and cognitive-behavior sex therapy (CBST) for the entire 8 weeks
Trial: 15675894
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (1 g three times a day for 2 weeks)
Trial: 11849797
Drug: Amifostine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (300 mg/m(2) administered 15-30 min before RT for 6-7.5 weeks)
Trial: 11849797
Drug: Conventional radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional radiotherapy and carboplatin (90 mg/m(2) infusion once per week before RT)
Trial: 25879690
Drug: Probiotic yogurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yogurt (100 g/day) + placebo capsule
Trial: 25879690
Drug: Probiotic capsule
RxNorm normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsule + conventional yogurt (100 g/day)
Trial: 25879690
Drug: Conventional yogurt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional yogurt (100 g/day) + placebo capsule
Trial: 23813627
Drug: CRP >1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP >1 mg/L